Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 436450, 12 pages
http://dx.doi.org/10.1155/2015/436450
Review Article

Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases

1Liver Unit and Center for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano, 20089 Milan, Italy
2State Key Laboratory for Oncogenes and Related Genes, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Cancer Institute, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, Shanghai 200001, China

Received 27 February 2015; Accepted 20 May 2015

Academic Editor: Jianfei Yang

Copyright © 2015 Haiyan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Haiyan Zhang, Francesca Bernuzzi, Ana Lleo, Xiong Ma, and Pietro Invernizzi, “Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases,” Mediators of Inflammation, vol. 2015, Article ID 436450, 12 pages, 2015. https://doi.org/10.1155/2015/436450.